American Heart Journal
Volume 147, Issue 2 , Pages 224-227 , February 2004

Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I

  • Deepak Bhakta, MD

      Affiliations

    • Department of Medicine, Krannert Institute of Cardiology, Indiana University, Indianapolis, Ind, USA
    • Corresponding Author InformationReprint requests: Deepak Bhakta, MD, Krannert Institute of Cardiology, Indiana University School of Medicine, 1800 North Capitol, Room E406, Indianapolis, IN 46202, USA.
    • ,
  • Miriam R Lowe, MS

      Affiliations

    • Department of Medicine, Krannert Institute of Cardiology, Indiana University, Indianapolis, Ind, USA
    • ,
  • William J Groh, MD

      Affiliations

    • Department of Medicine, Krannert Institute of Cardiology, Indiana University, Indianapolis, Ind, USA

Received 29 April 2003 ,Accepted 25 August 2003.

References 

  1. International Myotonic Dystrophy Consortium . New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). Neurology. 2000;54:1218–1221
  2. Gharehbaghi-Schnell EB, Finsterer J, Korschineck I. Genotype-phenotype correlation in myotonic dystrophy. Clin Genet. 1998;53:20–26
  3. Harper PS, Rudel R. Myotonic dystrophy. In:  Engel AG,  Franzini-Armstrong C editor. Myology (basic and clinics). New York: McGraw-Hill; 1994;p. 1192–1219
  4. Spranger M, Janssen B, Rating D. The clinical spectrum of patients with myotonic dystrophy with large triplet repeat expansion. Nervenarzt. 1999;70:131–135
  5. Thornton C. The myotonic dystrophies. Semin Neurol. 1999;19:25–33
  6. Kennel AJ, Titus L, Merideth J. Pathologic findings in the atrioventricular conduction system in myotonic dystrophy. Mayo Clin Proc. 1974;49:838–842
  7. Nguyen HH, Wolfe JT, Holmes DR. Pathology of the cardiac conduction system in myotonic dystrophy (a study of 12 cases). J Am Coll Cardiol. 1988;11:662–671
  8. Fisch C. The heart in dystrophia myotonica. Am Heart J. 1951;41:525–538
  9. Church SC. The heart in myotonia atrophica. Arch Intern Med. 1967;119:176–181
  10. Prystowsky EN, Pritchett EL, Roses AD. The natural history of conduction system disease in myotonic muscular dystrophy as determined by serial electrophysiologic studies. Circulation. 1979;60:1360–1364
  11. Motta J, Guilleminault C, Billingham M. Cardiac abnormalities in myotonic dystrophy (electrophysiologic and histopathologic studies). Am J Med. 1979;67:467–473
  12. Perloff JK, Stevenson WG, Roberts NK. Cardiac involvement in myotonic muscular dystrophy (Steinert's disease) (a prospective study of 25 patients). Am J Cardiol. 1984;54:1074–1081
  13. Moorman JR, Coleman RE, Packer DL. Cardiac involvement in myotonic muscular dystrophy. Medicine (Baltimore). 1985;64:371–387
  14. Hawley RJ, Milner MR, Gottdiener JS. Myotonic heart disease (a clinical follow-up). Neurology. 1991;41:259–262
  15. de Die-Smulders CE, Howeler CJ, Thijs C. Age and causes of death in adult-onset myotonic dystrophy. Brain. 1998;121:1557–1563
  16. Merino JL, Carmona JR, Fernandez-Lozano I. Mechanisms of sustained ventricular tachycardia in myotonic dystrophy (Implications for catheter ablation). Circulation. 1998;98:541–546
  17. Buxton J, Shelbourne P, Davies J. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. [comment] Nature. 1992;355:547–548
  18. Aslanidis C, Jansen G, Amemiya C. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature. 1992;355:548–551
  19. Tsilfidis C, MacKenzie AE, Mettler G. Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nat Genet. 1992;1:192–195
  20. Tokgozoglu LS, Ashizawa T, Pacifico A. Cardiac involvement in a large kindred with myotonic dystrophy (quantitative assessment and relation to size of CTG repeat expansion). JAMA. 1995;274:813–819
  21. Melacini P, Villanova C, Menegazzo E. Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol. 1995;25:239–245
  22. Groh WJ, Lowe MR, Zipes DP. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol. 2002;13:444–448
  23. Badano L, Autore C, Fragola PV. Left ventricular myocardial function in myotonic dystrophy. Am J Cardiol. 1993;71:987–991
  24. Mathieu J, Boivin H, Meunier D. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology. 2001;56:336–340
  25. Fu YH, Pizzuti A, Fenwick RG. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science. 1992;255:1256–1258
  26. Brook JD, McCurrach ME, Harley HG. Molecular basis of myotonic dystrophy (expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member). Cell. 1992;69:385
  27. Finsterer J, Gharehbagghi-Schnell E, Stollberger C. Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy. Clin Genet. 2001;59:350–355
  28. De Ambroggi L, Raisaro A, Marchiano V. Cardiac involvement in patients with myotonic dystrophy (characteristic features of magnetic resonance imaging). Eur Heart J. 1995;16:1007–1010
  29. Child JS, Perloff JK. Myocardial myotonia in myotonic muscular dystrophy. Am Heart J. 1995;129:982–990
  30. Hartwig GB, Rao KR, Radoff FM. Radionuclide angiocardiographic analysis of myocardial function in myotonic muscular dystrophy. Neurology. 1983;33:657–660

☆ Supported by grants from Medtronic, Inc (Minneapolis, Minn), the Muscular Dystrophy Association (Tucson, Ariz), and the National Institutes of Health (grant MO1-RR00750-27S1).

PII: S0002-8703(03)00636-7

doi: 10.1016/j.ahj.2003.08.008

American Heart Journal
Volume 147, Issue 2 , Pages 224-227 , February 2004

Article Tools